Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Thrombin alfa
Drug ID BADD_D02206
Description Thrombin Alfa is a human coagulation protein produced via recombinant DNA technology from a genetically modified CHO cell line. Thrombin Alfa is identical in amino acid sequence and structurally similar to naturally occurring human thrombin. Thrombin Alfa precursor is secreted to culture medium as single chain form that is proteolytically converted to a two-chain active form (using a protein derived from snakes) and is purified by a chromatographic process that yields a product having hemostatic activities similar to native human thrombin. The cell line used to manufacture Thrombin Alfa has been tested and shown to be free of known infectious agents. The cell culture process used in the manufacture of Thrombin Alfa employs no additives of human or animal origin. The purification process includes solvent-detergent treatment and nano-filtration steps dedicated to viral clearance. The thrombin alfa product ultimate comes from recombinant human prethrombin-1 [L2079]. Nevertheless, because the incidence of hemostasis within a timely manner is relatively comparable between the use of thrombin alfa and the placebo treatment in patient subjects, thrombin alfa is not currently approved by certain organizations like the European Medicines Agency [L2079].
Indications and Usage Indicated to aid hemostasis whenever oozing blood and minor bleeding from capillaries and small venules is accessible and control of bleeding by standard surgical techniques (such as suture, ligature, or cautery) is ineffective or impractical in adults and pediatric populations greater than or equal to one month of age [FDA Label]. Additionally, thrombin alfa can be used in conjunction with an absorbable gelatin sponge, USP [FDA Label].
Marketing Status approved
ATC Code Not Available
DrugBank ID DB11572
KEGG ID D09016
MeSH ID C513462
PubChem ID Not Available
TTD Drug ID Not Available
NDC Product Code 71124-0014
UNII SCK81AMR7R
Synonyms recombinant human thrombin | thrombin alfa topical | human thrombin (recombinant, glycosylated) | thrombin (synthetic human) | thrombin, recombinant human | thrombin alfa
Chemical Information
Molecular Formula Not Available
CAS Registry Number 869858-13-9
SMILES Not Available
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Atrial fibrillation02.03.03.002--
Cardiac arrest02.03.04.001--
Constipation07.02.02.001--
Hypersensitivity10.01.03.003--
Infection11.01.08.002--Not Available
Nausea07.01.07.001--
Postoperative wound infection12.02.05.011; 11.01.08.008--Not Available
Pruritus23.03.12.001--
Vomiting07.01.07.003--
Haemorrhage24.07.01.002--Not Available
Incision site pain12.02.05.006; 08.01.08.008--Not Available
Embolism24.01.01.009--
Antibody test positive13.06.03.001--Not Available
Procedural pain12.02.05.007; 08.01.08.009--Not Available
The 1th Page    1    Total 1 Pages